Monitor for subsequent Form 4 or 13F filings that may indicate AnaptysBio intends to distribute or sell shares of First Tracks to public investors, which could create trading opportunities. Evaluate First Tracks as a potential standalone entity in the biopharma sector.
Price Chart
Executive Summary
AnaptysBio, Inc. has spun off First Tracks Biotherapeutics, Inc. as a separate entity, with AnaptysBio retaining 100% ownership of First Tracks' common stock as of April 1, 2026. This Form 3 filing reflects the initial beneficial ownership report following the corporate separation.
Key Facts
- AnaptysBio, Inc. spun off First Tracks Biotherapeutics, Inc. effective April 1, 2026
- AnaptysBio retains 100% ownership of First Tracks' common stock post-spin-off
- First Tracks is a newly independent company formerly a wholly owned subsidiary of AnaptysBio
- This Form 3 is the initial beneficial ownership filing by AnaptysBio for shares of First Tracks
Financial Impact
Full ownership of 100 shares of common stock in newly separated entity; no monetary transaction disclosed
Risk Factors
- Uncertainty around future plans for First Tracks, including potential public offering, sale, or dissolution
- Limited financial or operational details about First Tracks disclosed in this filing
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001370053-26-000004 |
| Document: 0001370053-26-000004-index.html | 0001370053-26-000004 |
| Document: 0001370053-26-000004.txt | 0001370053-26-000004 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-1 | $43.80 | awaiting T+1 | — | $44.05 (+0.57%) |
Oct 20, 2026 5d ago | 8-K | $42.77 $43.14 | ▲ +0.87% | ▲ +2.05% | $44.05 (+2.99%) |
Oct 15, 2026 10d ago | 8-K | $34.46 $36.28 | ▼ −5.28% | ▼ −4.86% | $44.05 (−27.83%) |
Oct 15, 2026 11d ago | Press Release | $36.04 $34.46 | ▲ +4.38% | ▲ +3.28% | $44.05 (−22.23%) |
Oct 13, 2026 13d ago | 8-K | $31.68 $34.13 | ▲ +7.73% | ▲ +8.81% | $44.05 (+39.05%) |
Aug 12, 2026 10w ago | 8-K | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 12, 2026 10w ago | Press Release | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 7, 2026 11w ago | 3/A | $47.92 $46.75 | ▼ −2.44% | ▼ −2.12% | $44.05 (−8.08%) |
Jun 22, 2026 17w ago | 8-K | $17.78 $16.69 | ▼ −6.13% | ▼ −6.08% | $44.05 (+147.75%) |
May 14, 2026 23w ago | 8-K | $16.90 $17.79 | ▲ +5.27% | ▲ +5.33% | $44.05 (+160.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers